IDH1 and astrocytoma (excluding glioblastoma): The sarcomatous portion of the recurrence is distinctly astrocytic and clonally derived from the initial IDH-mutant astrocytoma, as demonstrated by an identical 17p CnLOH break-point and IDH1-R132C point mutations.